Stay updated on Genetically Engineered NY-ESO-1ᶜ²⁵⁹T Clinical Trial
Sign up to get notified when there's something new on the Genetically Engineered NY-ESO-1ᶜ²⁵⁹T Clinical Trial page.

Latest updates to the Genetically Engineered NY-ESO-1ᶜ²⁵⁹T Clinical Trial page
- Check6 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check13 days agoChange DetectedThe site revision number in the footer changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content with an access-denied screen. As a result, essential information about the trial, its documents, and locations is no longer accessible from this page.SummaryDifference21%

- Check55 days agoChange DetectedThe site's revision version was updated from v3.6.5 to v3.6.6, indicating a minor software release. This appears to be a small backend update with no visible changes to study details or public content.SummaryDifference0.0%

- Check62 days agoChange DetectedA new funding identifier '2015 ( U.S. NIH Grant/Contract )' was added to the study's identifiers, indicating NIH support for the trial.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing v3.6.4. This indicates a version update to the study page rather than a change to the study information itself.SummaryDifference0.0%

Stay in the know with updates to Genetically Engineered NY-ESO-1ᶜ²⁵⁹T Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Genetically Engineered NY-ESO-1ᶜ²⁵⁹T Clinical Trial page.